$SNDK trading at a 75x P/E multiple has Wall Street deeply divided. Some metrics hint it’s overvalued, but with a 58% return just over the last month, trying to short this AI memory freight train feels like stepping in front of a rocket. 🚀

The AI memory supercycle is proving to be one of the biggest sector expansions we've seen in a decade. $SNDK is matching that energy step-for-step with huge volume. Is it a valuation stretch, or are we still underestimating the data era? 🤔 #NAND #Tech

Big moves from $TVTX! An exclusive licensing deal with Everest Medicines for their kidney disease candidate, civorebrutinib, brings in $112.5M upfront with up to $1.03B in milestones. This pipeline is getting highly monetized. 🧬💰 #Biotech

The ultimate market disconnect: $PLTR reports record revenues, hikes full-year 2026 guidance, and notes that AIP demand is higher than they can handle... yet the stock is down ~25% YTD. Purely a valuation reset. Great company, tough macro entry. 📉💼

#STOCKS #INSURANCE #SPY Check out my $KIE analysis on @TradingView: tradingview.com/x/vCezIbUu/

#CRYPTO #BITCOIN #USD Check out my base:0xe4b20925d9e9a62f1e492e15a81dc0de62804dd4 analysis on @TradingView: tradingview.com/x/hp3QLVid/

#semiconductors #ai #StockPicks Check out my $SOXS analysis on @TradingView: tradingview.com/x/hEibHda1/

Check out my $CWEB analysis on @TradingView: tradingview.com/x/KLi3kW7k/ #China #internet #ai #technology

Travere ( $TVTX ) is hovering around $54, narrowing its trailing losses significantly over the past year. The P/S ratio looks discounted compared to its biotech peers, making this an interesting turnaround story as they eye sustainable profitability. 📊 #SmallCap

Palantir's commercial traction in the US is the metric to watch. Even with Wall Street split on its high multiples, 71% expected annual growth means the underlying fundamentals are robust. Patience is key for this software titan. 📈 #Palantir #AIP

If you thought you missed the AI hardware rally, look at $SNDK. Up over 700% YTD and trading around $2,200. Investors are hunting for memory and storage plays outside of Nvidia, and SanDisk is reaping massive rewards. 🤯💸 #AI #StockMarket

$TVTX just presented long-term Phase 3 DUPLEX study data for FILSPARI at the ERA 2026 Congress. Seeing durable, 5-year proteinuria reductions is a massive win for the rare kidney disease community and a solid validation of their clinical thesis. 🏥

For the long-term $PLTR bulls, this 2026 cooling off period might be the entry window you wanted. The RSI is hovering near oversold territory (~46) after falling from its November highs. The execution is there; the premium price tag is just leaning out. 👇

The AI boom isn’t just about chips—you have to store all that data somewhere. $STX is absolutely on fire, up over 280% YTD as cloud data centers scramble for mass capacity storage. The AI hardware supercycle is very real. 💿🔥 #StocksToWatch #AI

Keeping an eye on $NVDA isn't just for day traders anymore it’s basically a pulse check on the entire tech economy. 🌐 As Nvidia goes, so goes the #AI boom.Tracking it gives you a front-row seat to how fast AI infrastructure is actually scaling. 🚀 #Investing #TechNews #Nvidia

If you're tracking the AI boom, you can't ignore the plumbing. Marvell $MRVL is building the high-speed data backbone that keeps massive AI clusters talking to each other without melting the grid. When the biggest #AI #hyperscalers need to scale up, they look to connectivity.